{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:48:03Z","timestamp":1788029283511,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.biopha.2015.11.009","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T06:18:52Z","timestamp":1450160332000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats"],"prefix":"10.1016","volume":"77","author":[{"given":"Shivsharan B.","family":"Dhadde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nagakannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marulasiddeshwara","family":"Roopesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"Anand Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Thippeswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veeresh P.","family":"Veerapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Badami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.11.009_bib0005","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1602\/neurorx.1.1.128","article-title":"The paradigm of Huntington\u2019s disease: therapeutic opportunities in neurodegeneration","volume":"1","author":"Leegwater-Kim","year":"2004","journal-title":"NeuroRx."},{"key":"10.1016\/j.biopha.2015.11.009_bib0010","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/mds.21971","article-title":"The current clinical management of Huntington\u2019s disease","volume":"23","author":"Phillips","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2015.11.009_bib0015","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1523\/JNEUROSCI.18-23-10116.1998","article-title":"Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington\u2019s disease","volume":"18","author":"Reynolds","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2015.11.009_bib0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainresbull.2005.06.024","article-title":"Neuroprotective effect of nicotine against 3-nitropropionic acid induced experimental Huntington\u2019s disease in rats","volume":"67","author":"Tariq","year":"2005","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.biopha.2015.11.009_bib0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future","volume":"15","author":"Tunez","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2015.11.009_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tox.2007.11.003","article-title":"Protective effect of minocycline, a semi synthetic second generation tetracycline against 3-nitropropionic acid induced neurotoxicity","volume":"244","author":"Ahuja","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.biopha.2015.11.009_bib0035","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neures.2009.01.005","article-title":"Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide","volume":"63","author":"Kumar","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5214\/ans.0972.7531.2006.130204","article-title":"Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment","volume":"13","author":"Kumar","year":"2006","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.biopha.2015.11.009_bib0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.biopha.2015.11.009_bib0050","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3109\/01480545.2013.776583","article-title":"Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats","volume":"36","author":"Shivasharan","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0055","first-page":"139","article-title":"Effect of root extract of Withania somnifera in 3-nitropropionic acid-induced cognitive dysfunction and oxidative damage in rats","volume":"1","author":"Kumar","year":"2008","journal-title":"Int. J. Health Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0060","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/jnr.22017","article-title":"Ginsenosides protect striatal neurons in cellular model of Huntington\u2019s disease","volume":"87","author":"Wu","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1527-3458.2007.00017.x","article-title":"Lig-8, highly bioactive lignophenol derivative from bamboo lignin, exhibits multifaceted neuroprotective activity","volume":"13","author":"Ito","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.biopha.2015.11.009_bib0070","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (2)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington\u2019s disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2015.11.009_bib0075","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1742-7843.2010.00537.x","article-title":"Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats","volume":"107","author":"Kumar","year":"2010","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0080","first-page":"111","article-title":"Coenzyme Q10 serum levels in Huntington\u2019s disease","volume":"68","author":"Andrich","year":"2004","journal-title":"J. Neural Trans."},{"key":"10.1016\/j.biopha.2015.11.009_bib0085","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activate a heat shock response and inhibits huntingtin aggregation in cell culture model of Huntington\u2019s disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2015.11.009_bib0090","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mds.870110510","article-title":"A controlled trial of idebenone in Huntington\u2019s disease","volume":"11","author":"Ranen","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2015.11.009_bib0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2012.01.012","article-title":"Protective effect of Mimusops elengi Linn. flowers against middle cerebral artery occlusion induced brain injury in rats","volume":"140","author":"Nagakannan","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1615\/JEnvironPatholToxicolOncol.v31.i3.30","article-title":"Restoration of brain antioxidant status by hydroalcoholic extract of Mimusops elengi flowers in rats treated with monosodium glutamate","volume":"31","author":"Nagakannan","year":"2012","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12291-012-0256-1","article-title":"Protective effect of Calendula officinalis L. flowers against monosodium glutamate induced oxidative stress and excitotoxic brain damage in rats","volume":"28","author":"Shivasharan","year":"2013","journal-title":"Indian. J. Clin. Biochem."},{"key":"10.1016\/j.biopha.2015.11.009_bib0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12640-011-9258-7","article-title":"Protective effect of embelin from Embelia ribes Burm. against transient global ischemia induced brain damage in rats","volume":"20","author":"Thippeswamy","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0115","first-page":"481","article-title":"Anti-inflammatory agent in Indian laboratories","volume":"30","author":"Kapoor","year":"1983","journal-title":"Indian Drugs"},{"key":"10.1016\/j.biopha.2015.11.009_bib0120","volume":"2","author":"Varier","year":"2006"},{"key":"10.1016\/j.biopha.2015.11.009_bib0125","series-title":"Pharmacological Investigation of Certain Medicinal Plants and Compound Formulations used in Ayurveda and Siddha. Central Council for Research in Ayurveda and Siddha","author":"Pandey","year":"1996"},{"key":"10.1016\/j.biopha.2015.11.009_bib0130","first-page":"1","article-title":"Further studies on antioxidant potential and protection of pancreatic b-cells by Embelia ribes in experimental diabetes","volume":"2007","author":"Bhandari","year":"2007","journal-title":"Expt. Diab. Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/0253-7613.44153","article-title":"Protective effect of aqueous extract of Embelia ribes Burm fruits in middle cerebral artery occlusion induced focal cerebral ischemia in rats","volume":"40","author":"Bhandari","year":"2008","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0140","first-page":"521","article-title":"Protective effect of Embelia ribes Burm on methionine induced hyperhomocysteinemia and oxidative stress in rat brain","volume":"46","author":"Ansari","year":"2008","journal-title":"Indian J. Expt. Biol."},{"key":"10.1016\/j.biopha.2015.11.009_bib0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000239181","article-title":"Antitumor anti-inflammatory and analgesic property of embelin, a plant product","volume":"40","author":"Chitra","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.biopha.2015.11.009_bib0150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cbi.2007.02.004","article-title":"Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies","volume":"16","author":"Joshi","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.biopha.2015.11.009_bib0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bionut.2010.08.002","article-title":"Evaluation of antidiabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats","volume":"1","author":"Mahendran","year":"2011","journal-title":"Biomed. Prev. Nutr."},{"key":"10.1016\/j.biopha.2015.11.009_bib0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.phymed.2010.04.002","article-title":"Anticonvulsant activity of embelin isolated from Embelia ribes","volume":"18","author":"Mahendran","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2015.11.009_bib0165","article-title":"Piroxicam attenuates 3-nitropropionic acid-induced brain oxidative stress and behavioral alteration in mice","author":"Jadiswami","year":"2015","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.biopha.2015.11.009_bib0170","series-title":"Hand Book of Experimental Pharmacology","author":"Kulkarni","year":"1999"},{"key":"10.1016\/j.biopha.2015.11.009_bib0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2006.01.045","article-title":"Histamine improves rat rota-rod and balance beam performances through H2 receptors in the cerebellar interpositus nucleus","volume":"140","author":"Song","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2015.11.009_bib0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2006.11.021","article-title":"Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia","volume":"177","author":"Yan","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0185","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0028-3908(99)00262-2","article-title":"Functional assessments in mice and rats after focal stroke","volume":"39","author":"Hunter","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2015.11.009_bib0190","first-page":"2370","article-title":"Protein measurement with the phenol reagent","volume":"193","author":"Lowry","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.11.009_bib0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0304-4165(90)90100-B","article-title":"Different cellular targets of Cu- and Fe-catalyzed oxidation observed using a Cu-compatible thiobarbiturate acid assay","volume":"1035","author":"Gelvan","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2015.11.009_bib0200","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Archiv. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2015.11.009_bib0205","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","article-title":"GST the first enzymatic step in mercapturic acid formation","volume":"249","author":"Habig","year":"1974","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.11.009_bib0210","series-title":"CRC Handbook of Methods in Oxygen Radical Research","article-title":"Catalase activities","author":"Claiborne","year":"1985"},{"key":"10.1016\/j.biopha.2015.11.009_bib0215","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/01.STR.17.6.1304","article-title":"Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.biopha.2015.11.009_bib0220","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1568007053005073","article-title":"Mitochondria play a central role in estrogen-induced neuroprotection","volume":"4","author":"James","year":"2005","journal-title":"Curr. Drug Targets-CNS Neurol. Dis."},{"key":"10.1016\/j.biopha.2015.11.009_bib0225","series-title":"Huntington\u2019s Disease","author":"Harper","year":"1996"},{"key":"10.1016\/j.biopha.2015.11.009_bib0230","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.lfs.2009.10.001","article-title":"Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity","volume":"85","author":"Kumar","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2015.11.009_bib0235","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3 nitropropionic acid","volume":"10","author":"Beal","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2015.11.009_bib0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(00)01948-X","article-title":"3-nitropropionic acid-induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington's disease","volume":"858","author":"Fontaine","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2015.11.009_bib0245","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","article-title":"Quantifiable bradykinesia, gait abnormalities, and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid","volume":"79","author":"Guyot","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2015.11.009_bib0250","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0306-4522(95)00527-7","article-title":"Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases","volume":"71","author":"Schulz","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2015.11.009_bib0255","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","article-title":"Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation","volume":"15","author":"Reynolds","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2015.11.009_bib0260","first-page":"440","article-title":"Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging","volume":"16","author":"Bruce","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215300196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215300196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:59:09Z","timestamp":1760093949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215300196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":52,"alternative-id":["S0753332215300196"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.11.009","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}